Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001864093 | SCV002122408 | uncertain significance | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 152 of the MOCS1 protein (p.Gly152Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MOCS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1358481). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001864093 | SCV005668678 | uncertain significance | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2024-04-08 | criteria provided, single submitter | clinical testing |